Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Tamara L. Lotan, Alba Torres, Miao Zhang, Jeffrey J. Tosoian, Liana B. Guedes, Helen Fedor, Jessica Hicks, Charles M. Ewing, Sarah D. Isaacs, Dorhyun Johng, Angelo M. De Marzo, William B. Isaacs
Published Feb 8, 2017 · Vol. 8, No. 14 · pp. 22772-22782
Matthew Krilis, Miao Qi, Michele C. Madigan, Jason W.H. Wong, Mahmoud Abdelatti, Robyn H. Guymer, John Whitelock, Peter McCluskey, Peng Zhang, Jian Qi, Alex P. Hunyor, Steven A. Krilis, Bill Giannakopoulos
Published Feb 1, 2017 · Vol. 8, No. 30 · pp. 49016-49032
Charlotte Taylor, David Mannion, Fabrizio Miranda, Mohammad Karaminejadranjbar, Sandra Herrero-Gonzalez, Karin Hellner, Yiyan Zheng, Geoffrey Bartholomeusz, Robert C. Bast Jr, Ahmed Ashour Ahmed
Published Jan 31, 2017 · Vol. 8, No. 11 · pp. 17960-17980